Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Open in API
Filings indexed 1,061 across all filing types
Latest filing 2024-02-13 Major Shareholding Noti…
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A
Major Shareholding Notification
2024-02-13 English
JHG PLC OWNS >5%
Major Shareholding Notification
2024-02-13 English
SEC SCHEDULE 13G
Major Shareholding Notification
2024-02-10 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-26 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It discloses preliminary unaudited financial information for the year ended December 31, 2023, including net product revenue and cash position, but explicitly states that the information is preliminary and unaudited. The document also includes a press release as an exhibit. The content is an update on results of operations and financial condition but does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The Form 8-K is a regulatory filing used to announce material events and updates. Therefore, this document fits best under Regulatory Filings (RNS) as it is a current report providing preliminary financial information and a press release, not a full financial report or earnings release.
2024-01-08 English
FORM 4 SUBMISSION
Director's Dealing
2023-12-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.